SiFive, the leading provider of commercial RISC-V processor IP, today announced the availability of its E2 Core IP Series, configurable low-area, low-power microcontroller (MCU) cores designed for...

Abbott today announced results from multiple new clinical and real-world studies that provide a comprehensive look at the global use of the FreeStyle Libre system, the company's revolutionary...

Summer NAMM | Booth 801 -- C.F. Martin & Co.® (Martin Guitar) will offer two new black walnut guitars, a new Road Series guitar, and two additions to their ever-popular Monel® strings line this...

Inspired by insights from educators and administrators across the country, Bretford is introducing additions and upgrades to its family of mobile device charging products at ISTE 2018. This...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is highlighting its portfolio of molecular imaging solutions at the Society of Nuclear Medicine...

The world of work is rapidly changing, and data is increasingly fueling the human capital management function's ability to innovate to meet the needs of an evolving workforce. The second annual...

Hygieia, a digital insulin enhancement company dedicated to making insulin therapy easier for everyone involved, announced that expanded and updated results from a clinical trial evaluating its...

Life Science companies are facing new challenges related to ICH E6 (R2) guidelines and how they can respond in a way that achieves higher levels of transparency and speed, while implementing...

Harmonic (NASDAQ: HLIT), the worldwide leader in video delivery technology and services, today announced that PCCW Media Limited, the multimedia and entertainment subsidiary of PCCW Limited based...

Craneware (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today announced at the HFMA 2018 Annual Conference it is showcasing how the cloud-based Trisus platform...

As K-12 and higher education institutions increasingly adopt new digital learning techniques, investment in education technology will continue to surge, with the market expected to reach $40.9B by...

Eli Lilly and Company's (NYSE: LLY) Humulin® R U-500 administered via an investigational insulin pump (Omnipod® U-500™ Insulin Management System) provided greater A1C reduction with less daily...

Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, has been invited to participate in the 10th Annual CEO Summit, which is being held on July 11, 2018...

Elastifile, the pioneer of enterprise-grade, scalable file storage for the public cloud, today announced that eSilicon Corporation, an independent provider of FinFET-class ASICs, market-specific...

Chickapea, a fast-growing brand of high-protein pasta made from organic chickpeas and lentils, is proud to announce its certification as a B Corporation. The prestigious designation solidifies...

Acumatica, the world's fastest-growing cloud ERP company, today announced strong sales and partner support for Acumatica Construction Edition after just three months of availability. This...

DevOps Enterprise Summit #DOES18 -- CollabNet VersionOne (www.collabnet.com), a global leader in Enterprise Value Stream Management, ALM, and Agile-plus-DevOps, today announced its Enterprise...

For 35 years, BBK Worldwide has been on the crest of the wave with regard to the development and evolution of the patient recruitment industry. Today, the company announces its new marketplace...

At Metabolomics 2018 (metabolomics2018.org), Bruker today announced B.I.QUANT-PS™, a metabolite quantification solution on its AVANCE IVDr™ 600 MHz NMR platform, which brings cost-effective...

The executive management team from Sempra Energy (NYSE: SRE) will provide an update on the company's business strategy and financial goals at 9:30 a.m. EDT, June 28, on a live webcast from the...

Kalray (FR0010722819 - ALKAL), a pioneer in processors for new intelligent systems, is proud to announce inline processing and artificial intelligence at the International SuperComputing trade show in

DevOps Enterprise Summit #DOES18 -- CollabNet VersionOne (www.collabnet.com), a global leader in Enterprise Value Stream Management, ALM, and Agile-plus-DevOps, today announced its Enterprise...

Heaven Springs Dynasty Harvest Group (HSDH Group) attended the UN's International High-Level Conference on the Water Action Decade conference in Dushanbe, Tajikistan, and is a partner for the...

BroadcastAsia 2018 -- Verimatrix, a specialist in securing and enhancing revenue for network-connected devices and services, today announced delivery and implementation of Verimatrix's...

LinuxCon + ContainerCon + CloudOpen – The Cloud Native Computing Foundation® (CNCF®), which sustains and integrates open source technologies like Kubernetes® and Prometheus™, today...

LinuxCon China -- The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today announced at LinuxCon + ContainerCon + CloudOpen China in Beijing that TARS,...

LINUXCON CHINA --The Linux Foundation, the nonprofit organization enabling mass innovation through open source, has released Chinese translations of 10 Open Source Guides for the Enterprise,...

LinuxCon China -- The Linux Foundation, the nonprofit organization enabling mass innovation through open source, announces Tencent has become the latest Platinum member of the foundation. Tencent...

China is stepping into a new phase in this new age, is deeply implementing innovation-driven strategy, is speeding up building of an innovative state and is continuously promoting "Mass...

SMART Technologies launches new research at ISTE 2018 including a personalized profile configurator for schools to assess individual EdTech capabilities CALGARY, Alberta and CHICAGO, June 24, 2018...

Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that an abstract of a study in a preclinical...

People with type 1 diabetes (T1D) who take 200 mg or 400 mg of sotagliflozin in addition to optimized insulin therapy have statistically lower HbA1c levels and weight, as well as low incidence of...

Adding the selective SGLT2 inhibitor dapagliflozin to intensive insulin therapy in adults with type 1 diabetes (T1D) who had sub-optimal glycemic control reduced blood glucose levels, aided in...

Canagliflozin does not increase the risk of amputation for the general type 2 diabetes (T2D) population or in patients with established cardiovascular disease, but does reduce a patient's risk of...

When patients with type 2 diabetes (T2D) receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no...

People with diabetes who have experienced recent acute coronary syndrome (ACS) and take a combination of alirocumab and statins may reduce their risk of future cardiac events by more than double...

Adults with type 1 diabetes (T1D) who take a daily dose of liraglutide demonstrated improvements in HbA1c levels, weekly average blood glucose levels and increased weight loss, according to the...

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose Prediction and Automated Decision Support. Through...

New research finds that people with type 1 diabetes (T1D) who used the Diabeloop DBLG1 therapeutic, closed-loop insulin delivery system in a home setting experienced a greater percentage of time...

When adolescents and adults with type 1 diabetes (T1D) used a new continuous glucose monitoring (CGM) device containing a sensor that can remain implanted in the arm for up to 180 days, the system...

A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in adults with type 1 diabetes (T1D) compared to an...

Adults with type 1 diabetes using the Omnipod hybrid closed-loop system (the Horizon™ Automated Glucose Control System) were studied in a supervised outpatient hotel setting with unrestricted...

Findings from CONFIRM – a large, retrospective real-world evidence (RWE) study comparing the effectiveness of Tresiba® (insulin degludec injection) 100 U/mL, 200 U/mL versus insulin glargine...

Ozempic® (semaglutide) injection 0.5 mg or 1 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose co-transporter-2 inhibitor (SGLT2i) INVOKANA®...

Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from...

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME® trial, presented at the 78th American Diabetes...

With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual convention, from today through June 27 in Tampa, to see...

Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin glargine U-100 (1.94% vs 1.68% respectively;...

ViaCyte, Inc., a privately-held regenerative medicine company, today announced two-year data from Cohort 1 of the ongoing Safety, Tolerability, and Efficacy of VC-01™ (PEC-Encap™) Product...